Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
This study is currently recruiting participants.
Study NCT00704327   Information provided by Lahey Clinic
First Received: June 20, 2008   Last Updated: January 21, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

June 20, 2008
January 21, 2009
February 2008
Correlate quantitative measures of cerebral atrophic and ischemic changes with level of cognition using Mental Status Exam and Brain MRI exam [ Time Frame: One time visit, duration of MRI ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00704327 on ClinicalTrials.gov Archive Site
Establish reliable imaging criteria to identify normal age induced changes versus pathologic process comparing Mental Status Exam with Brain MRI(measuring CSF and Brain volumes) [ Time Frame: Duration of study 3 years ] [ Designated as safety issue: No ]
Same as current
 
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition

The purpose of this study is to evaluate whether or not cerebral atrophy scores obtained from a brain MRI can correlate with Cognitive Test results.

These results hope to demonstrate a link between cerebral ischemic/degenerative changes shown on the MRI and cognition functions results.

Preliminary evidence indicates that intracranial atherosclerosis may predict incident cerebrovascular events and central atrophy. Age induced changes on cerebral tissue in adulthood is witnessed as atrophy and well know ischemic changes on imaging studies. There is no consensus at this time what constitutes normal, age induced atrophy and pathologic atrophy on imaging studies. The same challenge is also encountered for ischemic cerebral parenchymal change. Until recently there have been several important limitations in this research 1) Measurement of cerebral tissue loss and amount of ischemic insult was based on a qualitative grading (2) There was no cognitive testing. With Advancements in software technology that have now allowed for measurements of CSF and brain volumes in reliable and reproducible ways and the neuroradiologist having access to the subject's Neurological Cognitive Testing Scores, this study will objectively measure MRI findings and correlate them with the level of cognitive function.

This study will look at subjects who have undergone cognitive testing from the Neurology Clinic and then referred for an MRI brain exam, as standard of care testing. The MRI information will be acquired by volumetric technique for calculation of brain and CSF volumes and MRI data will be plotted against the cognitive test results. The results of this study will be to correlate quantitative measures of cerebral atrophic and ischemic changes with level of cognition and to establish reliable imaging criteria that can help identify normal, age induced versus pathologic. Information obtained will shed light to cognitive effects and imaging appearance of: Separation of normal age related changes from pathologic states, changes leading to dementia and normal pressure hydrocephalus.

 
Observational
Case-Only, Cross-Sectional
Cognitive Decline
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
April 2012
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects older than 50 years of age
  • Subjects who have undergone Cognitive Testing
  • Subjects who can cooperate and give informed consent

Exclusion Criteria:

  • Subjects with known medical conditions predisposing them for atrophy such as: Chronic renal failure, HIV, head/neck tumors, prior radiation, post- traumatic brain disorder, metabolic disorders of brain, polysubstance abuse, and steroid use
Both
50 Years and older
No
Contact: Sami H. Erbay, M.D. 781-744-8170 Sami.Erbay@Lahey.org
United States
 
 
NCT00704327
Sami H. Erbay, M.D., Lahey Clinic, Inc.
 
Lahey Clinic
 
Principal Investigator: Sami H. Erbay, M.D. Lahey Clinic, Inc.
Lahey Clinic
January 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.